ARTICLE | Company News
Access Pharmaceuticals, Milestone Biosciences sales and marketing update
August 25, 2008 7:00 AM UTC
Access granted Milestone exclusive rights to market MuGard oral rinse to treat oral mucositis in North America. Access is eligible for up to $10 million in upfront and milestone payments, plus double...